Obesity and Age-Related Changes in the Brain of the Zucker
Aging
/ pathology
Animals
Astrocytes
/ pathology
Axons
/ pathology
Blood-Brain Barrier
/ pathology
Brain
/ cytology
Cognition
Disease Models, Animal
Glucose Transporter Type 1
/ metabolism
Male
Metabolic Syndrome
/ metabolism
Microglia
/ pathology
Neurodegenerative Diseases
/ etiology
Neurons
/ pathology
Obesity
/ metabolism
Rats, Zucker
Zucker rats
brain alterations
diabetes
metabolic syndrome
neuromorphology
obesity
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
09 May 2020
09 May 2020
Historique:
received:
11
03
2020
revised:
02
05
2020
accepted:
06
05
2020
entrez:
14
5
2020
pubmed:
14
5
2020
medline:
17
2
2021
Statut:
epublish
Résumé
Metabolic syndrome (MetS) is an association between obesity, dyslipidemia, hyperglycemia, hypertension, and insulin resistance. A relationship between MetS and vascular dementia was hypothesized. The purpose of this work is to investigate brain microanatomy alterations in obese Zucker rats (OZRs), as a model of MetS, compared to their counterparts lean Zucker rats (LZRs). 12-, 16-, and 20-weeks-old male OZRs and LZRs were studied. General physiological parameters and blood values were measured. Immunochemical and immunohistochemical techniques were applied to analyze the brain alterations. The morphology of nerve cells and axons, astrocytes and microglia were investigated. The blood-brain barrier (BBB) changes occurring in OZRs were assessed as well using aquaporin-4 (AQP4) and glucose transporter protein-1 (GLUT1) as markers. Body weight gain, hypertension, hyperglycemia, and hyperlipidemia were found in OZRs compared to LZRs. In the frontal cortex and hippocampus, a decrease of neurons was noticeable in the older obese rats in comparison to their age-matched lean counterparts. In OZRs, a reduction of neurofilament immunoreaction and gliosis was observed. The BBB of older OZRs revealed an increased expression of AQP4 likely related to the development of edema. A down-regulation of GLUT1 was found in OZRs of 12 weeks of age, whereas it increased in older OZRs. The behavioral analysis revealed cognitive alterations in 20-week-old OZRs. Based on these results, the OZRs may be useful for understanding the mechanisms through which obesity and related metabolic alterations induce neurodegeneration.
Identifiants
pubmed: 32397542
pii: nu12051356
doi: 10.3390/nu12051356
pmc: PMC7284640
pii:
doi:
Substances chimiques
Glucose Transporter Type 1
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Diabetes. 2004 May;53(5):1352-9
pubmed: 15111506
Trends Neurosci. 2000 Nov;23(11):542-9
pubmed: 11074263
Nat Rev Neurosci. 2015 May;16(5):249-63
pubmed: 25891508
PLoS One. 2017 May 2;12(5):e0176554
pubmed: 28463967
Brain Res. 2010 Apr 14;1325:155-63
pubmed: 20156423
Acta Neuropathol. 2015 Feb;129(2):279-95
pubmed: 25500713
Cell Death Differ. 2000 Oct;7(10):861-5
pubmed: 11279530
Adv Exp Med Biol. 1994;366:43-58
pubmed: 7771281
J Neurosci Res. 2003 Apr 15;72(2):141-6
pubmed: 12671988
Neuroimmunomodulation. 2012;19(2):121-30
pubmed: 22248728
Neurosci Lett. 2013 May 24;543:136-41
pubmed: 23545209
JAMA. 2013 Jan 2;309(1):71-82
pubmed: 23280227
Behav Genet. 1997 Jul;27(4):325-51
pubmed: 9519560
World J Diabetes. 2015 Apr 15;6(3):456-80
pubmed: 25897356
Br J Nutr. 2009 Nov;102(9):1246-53
pubmed: 19631025
Nutrients. 2020 Feb 27;12(3):
pubmed: 32120798
Brain Res Bull. 2016 Sep;126(Pt 3):334-346
pubmed: 27609296
Chin Med J (Engl). 2007 Oct 5;120(19):1704-9
pubmed: 17935675
Front Neurosci. 2018 Dec 11;12:930
pubmed: 30618559
Methods Mol Biol. 1998;108:101-6
pubmed: 9921519
Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1846-59
pubmed: 26475592
ILAR J. 2007;48(1):29-36
pubmed: 17170493
Diabet Med. 1999 May;16(5):442-3
pubmed: 10342346
Prim Care. 2018 Mar;45(1):109-129
pubmed: 29406938
Neurol Res. 2004 Jul;26(5):567-72
pubmed: 15265276
J Neuroimmune Pharmacol. 2006 Jun;1(2):127-37
pubmed: 18040779
Int J Eat Disord. 2017 Jun;50(6):624-635
pubmed: 28230907
BMC Geriatr. 2019 Mar 7;19(1):77
pubmed: 30845934
Front Neurosci. 2018 Apr 20;12:196
pubmed: 29731703
CNS Neurol Disord Drug Targets. 2018;17(8):595-603
pubmed: 30047340
CNS Spectr. 2008 Jul;13(7):606-13
pubmed: 18622365
Acta Diabetol. 2014 Aug;51(4):553-8
pubmed: 24477469
Physiol Behav. 2001 Apr;72(5):675-83
pubmed: 11336999
J Cereb Blood Flow Metab. 2010 Aug;30(8):1527-37
pubmed: 20424632
J Neurosci. 2014 Nov 12;34(46):15139-49
pubmed: 25392482
Indian J Med Res. 2007 Mar;125(3):451-72
pubmed: 17496368
Immunity. 2017 Jun 20;46(6):957-967
pubmed: 28636962
PLoS One. 2011;6(9):e24325
pubmed: 21949705
Front Endocrinol (Lausanne). 2018 Aug 31;9:496
pubmed: 30233495
Clin Exp Hypertens. 2004 May;26(4):305-21
pubmed: 15195686
CNS Neurol Disord Drug Targets. 2017;16(6):664-676
pubmed: 28462694
Cureus. 2018 May 21;10(5):e2660
pubmed: 30042911
Neurochem Res. 1996 May;21(5):595-602
pubmed: 8726968
Annu Rev Neurosci. 1996;19:187-217
pubmed: 8833441
Int J Neurosci. 2009;119(10):1881-904
pubmed: 19922391
Int J Mol Sci. 2020 Mar 16;21(6):
pubmed: 32188150
CNS Neurol Disord Drug Targets. 2016;15(8):995-1000
pubmed: 27238154
Behav Neurosci. 2005 Oct;119(5):1389-95
pubmed: 16300445
Clin Exp Hypertens. 2017;39(1):8-16
pubmed: 28071980
Dement Geriatr Cogn Dis Extra. 2014 Jun 28;4(2):184-94
pubmed: 25337075
Curr Opin Neurobiol. 1995 Apr;5(2):205-16
pubmed: 7620309
J Comp Neurol. 2015 Apr 1;523(5):757-68
pubmed: 25380530
Obesity (Silver Spring). 2007 Jan;15(1):216-24
pubmed: 17228050
Int Rev Neurobiol. 2016;127:89-112
pubmed: 27133146
Psychopharmacology (Berl). 2013 Jul;228(1):53-63
pubmed: 23455592
Neurol Res. 2014 Sep;36(9):824-32
pubmed: 24571083
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
Nat Rev Neurosci. 2014 Apr;15(4):209-16
pubmed: 24646669
Nutrients. 2017 Sep 29;9(10):
pubmed: 28961195
Brain Res. 2006 Mar 3;1076(1):9-15
pubmed: 16487498
Lancet. 2011 Mar 26;377(9771):1085-95
pubmed: 21397319
Mech Ageing Dev. 2001 Nov;122(16):2085-105
pubmed: 11589925
Neuroreport. 2008 Jan 8;19(1):1-5
pubmed: 18281883
Circulation. 2006 Feb 14;113(6):898-918
pubmed: 16380542